サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1701862

爪真菌症治療市場レポート：疾患タイプ別、治療タイプ別、薬剤クラス別、流通チャネル別、地域別、2025年～2033年

Onychomycosis Treatment Market Report by Disease Type, Treatment Type, Drug Class, Distribution Channel, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 143 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
爪真菌症治療市場レポート：疾患タイプ別、治療タイプ別、薬剤クラス別、流通チャネル別、地域別、2025年～2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

爪真菌症治療市場の世界市場規模は2024年に36億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに54億米ドルに達し、2025～2033年の成長率（CAGR）は4.5％になると予測しています。公共のスイミングプールに入る機会が増え、窮屈で汚染された、または汚れた衣服、靴、靴下などを使用するため、成人およびミレニアル世代の間でこの真菌感染症の有病率が上昇していることが、主に市場を牽引しています。

爪真菌症は、指の爪や足の爪に発生する真菌感染症で、不快感や慢性的な痛み、外見の醜さにつながる可能性があります。爪甲真菌症には、近位爪下、白色表在性、遠位爪下があります。爪水虫患者によくみられる爪感染症で、皮膚糸状菌、酵母、非皮膚糸状菌のカビなど様々な生物によって引き起こされます。爪真菌症は、爪の形の歪み、悪臭、白色から黄褐色の変色、爪のもろさ、ボロボロ、ガサガサといった症状が特徴です。通常、カリウム、酸素、水素（KOH）検査、培養、爪切りや爪生検の病理組織学的検査によって診断され、レーザー治療、薬物治療、光線力学的治療によって治療されます。

爪真菌症治療市場傾向：

爪甲真菌症、ヒト免疫不全ウイルス（HIV）、糖尿病、末梢動脈疾患（PAD）などの慢性疾患の有病率の増加は、市場の成長を促進する主な要因の1つです。さらに、循環障害や免疫力の低下を起こしやすい老年人口の増加が、市場の成長を後押ししています。爪真菌症はまた、公共のスイミングプールに入る機会が増え、窮屈で汚染された、または汚れた衣服、靴、靴下を使用するため、ミレニアル世代や成人の間で非常に流行しています。さらに、経口投与が可能な水溶性抗真菌治療液の開発が市場の成長を後押ししています。これらは細菌の二次感染を防ぎ、真菌の増殖を防ぐのに役立ちます。その他、爪の衛生状態を維持するために外用ネイルラッカーや軟膏が広く利用されていること、ヘルスケアインフラの大幅な改善などが、市場の成長を後押しすると予測されます。

本レポートで扱う主な質問

  • 2024年の世界の爪真菌症治療市場の市場規模は？
  • 2025-2033年における世界の爪真菌症治療市場の予想成長率は？
  • 世界の爪真菌症治療市場を牽引する主要因は何か？
  • 世界の爪真菌症治療市場に対するCOVID-19の影響は？
  • 世界の爪真菌症治療市場の疾患タイプ別内訳は？
  • 世界の爪真菌症治療市場の治療タイプ別の内訳は？
  • 世界の爪真菌症治療市場の販売チャネル別の内訳は？
  • 世界の爪真菌症治療市場における主要地域は？
  • 世界の爪真菌症治療市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の爪真菌症治療市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：疾患タイプ別

  • 遠位爪下爪真菌症
  • 近位爪下爪真菌症
  • 白色表在性爪白癬
  • カンジダ性爪真菌症
  • その他

第7章 市場内訳：治療タイプ別

  • レーザー療法
  • 光線力学療法
  • 薬物治療

第8章 市場内訳：薬剤クラス別

  • アリルアミン
  • アゾール
  • グリセオフルビン
  • その他

第9章 市場内訳：流通チャネル別

  • 病院と診療所
  • オンラインストア
  • 小売薬局
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Bausch Health Companies Inc.
    • Cipla Limited
    • Dr. Reddy's Laboratories
    • Galderma SA
    • GlaxoSmithKline PLC
    • Kaken Pharmaceutical Co. Ltd
    • Lumenis Ltd
    • Moberg Pharma AB
    • Novartis AG
    • Pfizer Inc.
    • The OTC Lab B.V.
図表

List of Figures

  • Figure 1: Global: Onychomycosis Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Onychomycosis Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Onychomycosis Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Onychomycosis Treatment Market: Breakup by Disease Type (in %), 2024
  • Figure 5: Global: Onychomycosis Treatment Market: Breakup by Treatment Type (in %), 2024
  • Figure 6: Global: Onychomycosis Treatment Market: Breakup by Drug Class (in %), 2024
  • Figure 7: Global: Onychomycosis Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Onychomycosis Treatment Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Onychomycosis Treatment (Distal Subungual Onychomycosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Onychomycosis Treatment (Distal Subungual Onychomycosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Onychomycosis Treatment (Proximal Subungual Onychomycosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Onychomycosis Treatment (Proximal Subungual Onychomycosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Onychomycosis Treatment (White Superficial Onychomycosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Onychomycosis Treatment (White Superficial Onychomycosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Onychomycosis Treatment (Candidal Onychomycosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Onychomycosis Treatment (Candidal Onychomycosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Onychomycosis Treatment (Other Disease Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Onychomycosis Treatment (Other Disease Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Onychomycosis Treatment (Laser Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Onychomycosis Treatment (Laser Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Onychomycosis Treatment (Photodynamic Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Onychomycosis Treatment (Photodynamic Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Onychomycosis Treatment (Drug Treatment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Onychomycosis Treatment (Drug Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Onychomycosis Treatment (Allylamine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Onychomycosis Treatment (Allylamine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Onychomycosis Treatment (Azole) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Onychomycosis Treatment (Azole) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Onychomycosis Treatment (Griseofulvin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Onychomycosis Treatment (Griseofulvin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Onychomycosis Treatment (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Onychomycosis Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Onychomycosis Treatment (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Onychomycosis Treatment (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Onychomycosis Treatment (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Onychomycosis Treatment (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Onychomycosis Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Onychomycosis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Onychomycosis Treatment (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Onychomycosis Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: North America: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: North America: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: United States: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: United States: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Canada: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Canada: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Asia-Pacific: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Asia-Pacific: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: China: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: China: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Japan: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Japan: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: India: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: India: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: South Korea: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: South Korea: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Australia: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Australia: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Indonesia: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Indonesia: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Others: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Europe: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Europe: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Germany: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Germany: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: France: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: France: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: United Kingdom: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: United Kingdom: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Italy: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Italy: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Spain: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Spain: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Russia: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Russia: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Latin America: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Latin America: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Brazil: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Brazil: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Mexico: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Mexico: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Others: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Middle East and Africa: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Middle East and Africa: Onychomycosis Treatment Market: Breakup by Country (in %), 2024
  • Figure 89: Middle East and Africa: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Global: Onychomycosis Treatment Industry: SWOT Analysis
  • Figure 91: Global: Onychomycosis Treatment Industry: Value Chain Analysis
  • Figure 92: Global: Onychomycosis Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Onychomycosis Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Onychomycosis Treatment Market Forecast: Breakup by Disease Type (in Million USD), 2025-2033
  • Table 3: Global: Onychomycosis Treatment Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
  • Table 4: Global: Onychomycosis Treatment Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 5: Global: Onychomycosis Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Onychomycosis Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Onychomycosis Treatment Market: Competitive Structure
  • Table 8: Global: Onychomycosis Treatment Market: Key Players
目次
Product Code: SR112025A4877

The global onychomycosis treatment market size reached USD 3.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.5% during 2025-2033. The rising prevalence of this fungal infection among adults and millennials due to the increased exposure to public swimming pools and the use of tight, contaminated, or soiled clothes, shoes, socks, etc., is primarily driving the market.

Onychomycosis is a fungal infection that occurs in the fingernails and toenails that can lead to discomfort, chronic pain and disfigurement. Proximal subungual, white superficial and distal subungual are some of the types of onychomycosis. It is a common nail infection in patients with athlete's foot and is caused by various organisms, such as dermatophytes, yeasts and non-dermatophyte molds. Onychomycosis is characterized by symptoms, including distortion in the shape of nails, foul smell, whitish to yellow-brown discoloration and brittle, ragged and crumbly texture of the nails. It is usually diagnosed through potassium, oxygen and hydrogen (KOH) examination, culture and histopathological examinations of nail clippings and nail biopsies and is treated through laser therapy, drugs and photodynamic therapies.

Onychomycosis Treatment Market Trends:

The increasing prevalence of chronic medical ailments, such as onychomycosis, human immunodeficiency virus (HIV), diabetes and peripheral artery disease (PAD), is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is highly prone to circulatory disorders and weakened immune system, is providing a thrust to the market growth. Onychomycosis is also highly prevalent among millennials and adults due to the increased exposure to public swimming pools and utilization of tight, contaminated or soiled clothes, shoes and socks. Additionally, the development of water-soluble antifungal treatment solutions that can be administered orally is providing a thrust to the market growth. They aid in preventing secondary bacterial infections and prevent the growth of fungus. Other factors, including the widespread utilization of topical nail lacquers and ointments to maintain nail hygiene, along with the significant improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Disease Type:

  • Distal Subungual Onychomycosis
  • Proximal Subungual Onychomycosis
  • White Superficial Onychomycosis
  • Candidal Onychomycosis
  • Others

Breakup by Treatment Type:

  • Laser Therapy
  • Photodynamic Therapy
  • Drug Treatment

Breakup by Drug Class:

  • Allylamine
  • Azole
  • Griseofulvin
  • Others

Breakup by Distribution Channel:

  • Hospitals and Clinics
  • Online Stores
  • Retail Pharmacies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bausch Health Companies Inc., Cipla Limited, Dr. Reddy's Laboratories, Galderma SA, GlaxoSmithKline PLC, Kaken Pharmaceutical Co. Ltd, Lumenis Ltd, Moberg Pharma AB, Novartis AG, Pfizer Inc. and The OTC Lab B.V.

Key Questions Answered in This Report

  • 1.What was the size of the global onychomycosis treatment market in 2024?
  • 2.What is the expected growth rate of the global onychomycosis treatment market during 2025-2033?
  • 3.What are the key factors driving the global onychomycosis treatment market?
  • 4.What has been the impact of COVID-19 on the global onychomycosis treatment market?
  • 5.What is the breakup of the global onychomycosis treatment market based on the disease type?
  • 6.What is the breakup of the global onychomycosis treatment market based on the treatment type?
  • 7.What is the breakup of the global onychomycosis treatment market based on the distribution channel?
  • 8.What are the key regions in the global onychomycosis treatment market?
  • 9.Who are the key players/companies in the global onychomycosis treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Onychomycosis Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Disease Type

  • 6.1 Distal Subungual Onychomycosis
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Proximal Subungual Onychomycosis
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 White Superficial Onychomycosis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Candidal Onychomycosis
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Laser Therapy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Photodynamic Therapy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Drug Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Drug Class

  • 8.1 Allylamine
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Azole
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Griseofulvin
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Online Stores
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Retail Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bausch Health Companies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Cipla Limited
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Dr. Reddy's Laboratories
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Galderma SA
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 GlaxoSmithKline PLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Kaken Pharmaceutical Co. Ltd
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Lumenis Ltd
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 SWOT Analysis
    • 15.3.8 Moberg Pharma AB
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Novartis AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 The OTC Lab B.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio